中文产业新闻评分56Chinese source
uniQure亨廷顿病基因疗法AMT-130 I/II期主要终点未达统计学显著 股价跌37%
临床失败，股价暴跌37%
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
临床失败，股价暴跌37%
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.